2015
DOI: 10.4172/2329-9517.1000195
|View full text |Cite
|
Sign up to set email alerts
|

Long-term Cost-effectiveness of Endoscopic vs Open Vein Harvest for Coronary Artery Bypass Grafting

Abstract: Background: The greater saphenous vein is frequently used as a conduit for coronary artery bypass grafting (CABG). Previously, veins were most often harvested using open vein harvesting (OVH), however, endoscopic vein harvesting (EVH) techniques have become increasingly popular. Nevertheless, the long-term cost-effectiveness of EVH remains unknown. The present study estimated the long-term cost-effectiveness of EVH versus OVH for CABG.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(5 citation statements)
references
References 31 publications
0
0
0
Order By: Relevance
“…This is because lower costs further downstream in the treatment pathway outweigh the initial higher investment for the EVH equipment. Our findings are in line with the results from Oddershede and Andreasen,14 who found EVH to be cost-effective, with a dominant ICER of £8219 per QALY, and the findings by Luckraz and colleagues,20 who identified cost savings of £856 per EVH patient. Similar…”
supporting
confidence: 92%
See 4 more Smart Citations
“…This is because lower costs further downstream in the treatment pathway outweigh the initial higher investment for the EVH equipment. Our findings are in line with the results from Oddershede and Andreasen,14 who found EVH to be cost-effective, with a dominant ICER of £8219 per QALY, and the findings by Luckraz and colleagues,20 who identified cost savings of £856 per EVH patient. Similar…”
supporting
confidence: 92%
“…Specifically in the United Kingdom's National Health Service (NHS), costs per quality-adjusted life-year (QALY) gained are an important criterion in decision-making processes for the adoption of new health technologies. 11 To date, only few economic evaluations on EVH have been published, delivering different conclusions on the cost-effectiveness of EVH, 6,[12][13][14][15] while focusing only on a short-term analytic horizon. To enable more precise and informed decision making on the adoption of EVH as standard of care in the United Kingdom, 10,12 cohort only during the first cycle (transition to a different state after the first cycle).…”
mentioning
confidence: 99%
See 3 more Smart Citations